Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bortezomib (velcade) (1 trial)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Trials (1 total)
Trial APIs (1 total)